Aemetis Earnings Call: RNG Strength Amid Heavy Spend

Aemetis Inc ((AMTX)) has held its Q4 earnings call. Read on for the main highlights of the call.

Aemetis’ latest earnings call struck a cautiously optimistic tone as management highlighted sharp quarterly margin gains and profitable growth in its dairy renewable natural gas business, even while acknowledging a weaker full-year top line and sizable ongoing losses. Policy support and fully financed strategic projects underpinned confidence, but execution and regulatory timing risks remain front and center for investors.

Quarterly Results Show Sharp Turn in Profitability

Aemetis delivered a markedly better fourth quarter, with revenue plus tax credits climbing 14.3% year over year to $53.7 million. Gross profit swung from a $2.0 million loss to a $7.7 million gain, while operating loss narrowed to $2.5 million and net loss improved to $5.3 million, signaling meaningful operating leverage emerging in the core business.

Full-Year Revenue Slips but Losses Narrow

For full-year 2025, revenue plus tax credits fell 22.4% to $208 million from $268 million, underscoring the scale of the top-line reset despite the strong quarter. Even so, operating loss improved to $37.2 million and net loss to $77.0 million from $87.5 million, showing gradual progress toward breakeven but leaving the company still meaningfully in the red.

Dairy RNG Emerges as Profit Engine

The biogas and dairy RNG segment remained a standout, generating $12.2 million of net income in 2025 on roughly 405,000 MMBtu of production from 12 operating digesters. Production jumped 61% year over year in the fourth quarter, and management sees this unit as a key cash flow driver as more digesters come online and 45Z tax credit monetization ramps.

MVR Project Poised to Transform Keyes Economics

At the Keyes ethanol plant, Aemetis is advancing a roughly $40 million mechanical vapor recompression project that is fully financed and largely spent. Once completed, it is expected to cut natural gas use by about 80%, lower carbon intensity, and lift plant cash flow by around $32 million annually, with management pointing to roughly $3–4 million per month in combined benefit from MVR and 45Z.

Stronger Credits and Tax Incentives Fuel Upside

The company booked $10.3 million of production tax credits in the fourth quarter from its ethanol and RNG operations, signaling growing monetization of clean-fuel incentives. Rising LCFS prices, which management said moved from roughly $40 to about $70, along with favorable guidance on the 45Z production tax credit, are increasingly important levers for revenue and cash flow expansion.

Core Assets Provide Scalable Platform

Operationally, the Keyes ethanol plant remains the workhorse, generating $158 million in revenue in 2025 with roughly 65 million gallons of annual capacity. In India, Aemetis’ biodiesel business produced $29.7 million in revenue and operates about 80 million gallons of biodiesel and 8 million gallons of glycerin capacity, with management eyeing opportunities in compressed biogas and sustainable aviation fuel.

Financing Supports Biogas and Infrastructure Expansion

Management stressed that both the MVR project and a $27 million contract for H2S cleanup and compression units are fully financed, reducing near-term funding uncertainty around key initiatives. Longer term, the company closed 20-year financings for two biogas entities and is pursuing additional structures to back its planned build-out of digesters and related RNG infrastructure.

Revenue Decline Highlights Transition Phase

Despite the strong fourth quarter, the roughly 22.4% drop in full-year revenue plus tax credits to $208 million underscores that Aemetis is still navigating a transition period. The company is leaning heavily on future benefits from tax credits and low-carbon fuel demand to offset current revenue pressure as legacy markets and pricing remain challenging.

Material Net Losses Persist Despite Progress

Even with narrowed losses, Aemetis still posted a sizable $77.0 million net loss for 2025, only modestly better than the $87.5 million loss a year earlier. Investors will be watching whether the combination of RNG growth, MVR-driven cost savings, and richer credit monetization can finally push the business closer to sustainable profitability over the next few years.

Large Capital Program Brings Opportunity and Risk

The growth plan remains capital intensive, with the roughly $40 million MVR project, the $27 million H2S and compression contract, and an estimated $70 million program to build the next 15 digesters extending into 2027. While management points to secured and planned financings, the scale and timing of these projects present execution and funding risks that could pressure the balance sheet if schedules slip.

Regulatory Timing Clouds 45Z Upside

Aemetis’ earnings trajectory is increasingly tethered to policy implementation, particularly around the 45Z production tax credit and revised GREET emissions modeling. Management emphasized that key upside depends on the timely release of federal guidance and related calculations, which introduces uncertainty around when the company can fully capture the value it expects from low-carbon fuel production.

Most 45Z Value Still Ahead

So far, the company has only monetized a limited portion of its potential 45Z benefit, with management previously citing about $5 million realized. That leaves a substantial pool of expected value that has yet to flow through the income statement, amplifying both the future earnings opportunity and the near-term sensitivity to regulatory clarity and market demand for low-carbon fuels.

India Operations Face Policy-Driven Volatility

In India, management described a “start–stop” environment for biodiesel demand, driven by shifting domestic policies and geopolitical factors that affect pricing and volumes. While long-term mandates and energy needs remain supportive, this volatility adds uncertainty to the planned India subsidiary IPO and to expansion into compressed biogas and sustainable aviation fuel.

Guidance Signals 2026 as Inflection Year

Looking ahead, Aemetis is positioning 2026 as a potential inflection point, with completion of the MVR project at Keyes targeted to start benefiting results by the third quarter and fully by the fourth. Combined with planned RNG growth from additional digesters, higher 45Z monetization, improved LCFS pricing, and ongoing refinancing efforts, management is guiding to materially higher cash flow and profitability versus the 2025 baseline of $208 million in revenue plus tax credits.

Aemetis’ earnings call painted the picture of a company in the midst of a capital-heavy transition, with profitable RNG operations and rising tax-credit monetization starting to offset legacy headwinds and persistent losses. For investors, the story now hinges on timely execution of financed projects and on stable, supportive policy frameworks that can unlock the full earnings power management outlined for the coming years.